Brief: Aytu Biopharma Regains Nasdaq Minimum Bid Price Compliance
25/01/2023 13:10
Jan 25 (Reuters) - Aytu Biopharma Inc AYTU.O :
* AYTU BIOPHARMA REGAINS NASDAQ MINIMUM BID PRICE COMPLIANCE
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aytu Biopharma
See all newsAytu Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Aytu BioPharma Q4 revenue beats analyst estimates on EXXUA sales
Aytu Biopharma Inc expected to post a loss of 32 cents a share - Earnings Preview
Aytu BioPharma Q3 revenue falls amid EXXUA launch
Aytu BioPharma Q2 revenue beats expectations